Search

Search Constraints

You searched for: Author/Creator Bertoletti, Federico

Search Results

1. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis. Issue 8 (30th June 2017)

2. Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis. (3rd July 2019)

3. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti‐TNF‐α: results from the ENEIDA registry. Issue 9 (14th March 2021)